BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 8926944)

  • 1. [Dopamine receptor subtypes].
    Janković SM; Milovanović D; Mitrović M; Dukić-Dejanović S
    Med Pregl; 1996; 49(7-8):281-5. PubMed ID: 8926944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The peripheral dopaminergic system: morphological analysis, functional and clinical applications.
    Amenta F; Ricci A; Tayebati SK; Zaccheo D
    Ital J Anat Embryol; 2002; 107(3):145-67. PubMed ID: 12437142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of dopamine in the pathogenesis of hypertension.
    Jose PA; Eisner GM; Felder RA
    Clin Exp Pharmacol Physiol Suppl; 1999 Apr; 26():S10-3. PubMed ID: 10386248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The brain dopaminergic systems: receptor heterogeneity, functional role and pharmacological regulation].
    Raevskiĭ KS; Sotnikova TD; Gaĭnetdinov RR
    Usp Fiziol Nauk; 1996; 27(4):3-29. PubMed ID: 9019922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of selective dopamine receptor subtype agonists on cardiac contractility and regional haemodynamics in rats.
    Polakowski JS; Segreti JA; Cox BF; Hsieh GC; Kolasa T; Moreland RB; Brioni JD
    Clin Exp Pharmacol Physiol; 2004 Dec; 31(12):837-41. PubMed ID: 15659045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The dopaminergic system in hypertension.
    Zeng C; Zhang M; Asico LD; Eisner GM; Jose PA
    Clin Sci (Lond); 2007 Jun; 112(12):583-97. PubMed ID: 17492945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diversity of dopamine receptors: new molecular and pharmacological developments.
    Hartman DS; Lanau F
    Pol J Pharmacol; 1997 Aug; 49(4):191-9. PubMed ID: 9437762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dopaminergic receptors: structural features and functional implications].
    Nieoullon A; Amalric M
    Rev Neurol (Paris); 2002 Dec; 158 Spec no 1():S59-68. PubMed ID: 12690665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Negative feedback regulation of nigrostriatal dopamine release: mediation by striatal D1 receptors.
    Saklayen SS; Mabrouk OS; Pehek EA
    J Pharmacol Exp Ther; 2004 Oct; 311(1):342-8. PubMed ID: 15175419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine receptors and antipsychotic drug response.
    Sunahara RK; Seeman P; Van Tol HH; Niznik HB
    Br J Psychiatry Suppl; 1993 Dec; (22):31-8. PubMed ID: 7906523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine receptor subtypes in the human pulmonary arterial tree.
    Ricci A; Mignini F; Tomassoni D; Amenta F
    Auton Autacoid Pharmacol; 2006 Oct; 26(4):361-9. PubMed ID: 16968475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Brain dopamine receptors: structure, functional role, and modulation by psychotropic substances].
    Raevskiĭ KS
    Vopr Med Khim; 1997; 43(6):553-65. PubMed ID: 9503573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local application of dopamine inhibits pyramidal tract neuron activity in the rodent motor cortex.
    Awenowicz PW; Porter LL
    J Neurophysiol; 2002 Dec; 88(6):3439-51. PubMed ID: 12466459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine D3 and D4 receptor antagonists in the treatment of schizophrenia.
    Jardemark K; Wadenberg ML; Grillner P; Svensson TH
    Curr Opin Investig Drugs; 2002 Jan; 3(1):101-5. PubMed ID: 12054059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. D2S, D2L, D3, and D4 dopamine receptors couple to a voltage-dependent potassium current in N18TG2 x mesencephalon hybrid cell (MES-23.5) via distinct G proteins.
    Liu LX; Burgess LH; Gonzalez AM; Sibley DR; Chiodo LA
    Synapse; 1999 Feb; 31(2):108-18. PubMed ID: 10024007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopaminergic receptors: a new antihypertensive mechanism.
    Velasco M; Contreras F; Cabezas GA; Bolívar A; Fouillioux C; Hernández R
    J Hypertens Suppl; 2002 Jun; 20(3):S55-8. PubMed ID: 12184056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Brain dopamine receptors: molecular aspects and functional implications].
    Nieoullon A; Amalric M
    Rev Neurol (Paris); 2002; 158(122):59-68. PubMed ID: 12690316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenosine receptor-dopamine receptor interactions in the basal ganglia and their relevance for brain function.
    Fuxe K; Ferré S; Genedani S; Franco R; Agnati LF
    Physiol Behav; 2007 Sep; 92(1-2):210-7. PubMed ID: 17572452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine receptors: subtypes, localization and regulation.
    Creese I; Sibley DR; Leff S; Hamblin M
    Fed Proc; 1981 Feb; 40(2):147-52. PubMed ID: 7007083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SPECT tracer [(123)I]IBZM has similar affinity to dopamine D2 and D3 receptors.
    Videbaek C; Toska K; Scheideler MA; Paulson OB; Moos Knudsen G
    Synapse; 2000 Dec; 38(3):338-42. PubMed ID: 11020237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.